12. Internation Symposium on Pharmaceutical Sciences (ISOPS 12), Ankara, Turkey, 26 - 29 June 2018, pp.329-330
Nanoparticles are one of the multiparticulate delivery systems and are prepared to improve bioavailability or stability (1). The object of the study was to formulate and characterize Eudragit® Nanoparticles containing carvedilol by determining their size and zeta potential, their external morphology for the treatment of hypertension.